CAS: 1509916-03-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Cergutuzumab REF: 3D-CLA1643CAS: 1509916-03-3 | - - - | To inquire | Tue 17 Dec 24 |
| Cergutuzumab Amunaleukin REF: 3D-CLA1643ACAS: 1509916-03-3 | - - - | To inquire | Tue 17 Dec 24 |
 | Cergutuzumab amunaleukin REF: TM-T76944CAS: 1509916-03-3 | 99.7% (SEC-HPLC) - 99.7% (SEC-HPLC) | 389.00 €~3,238.00 € | Fri 07 Feb 25 |
Cergutuzumab
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Cergutuzumab Amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with …
Ref: 3D-CLA1643A
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Cergutuzumab amunaleukin
CAS:1509916-03-3
Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor …
Purity:
99.7% (SEC-HPLC) - 99.7% (SEC-HPLC)
Color and Shape:
Liquid
Molecular weight:
162.05 kDa
Ref: TM-T76944
| 1mg | 389.00 € | ||
| 5mg | 989.00 € | ||
| 10mg | 1,615.00 € | ||
| 25mg | 2,385.00 € | ||
| 50mg | 3,238.00 € |
Estimated delivery in United States, on Friday 7 Feb 2025
